Japan Hosts $390 Million in Vaccine-Related Pharma Projects

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking nine capital projects in Japan's Pharmaceutical & Biotech Industry geared toward vaccine-manufacturing, totaling more than US$390 million in investment value.

The projects include FUJIFILM Toyama Chemical Company Limited's (Toyama, Japan) mRNA vaccines building addition in Toyama. Construction is expected to begin in the first quarter of 2025 and wrap up in 2027. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical-Biotech Project Database can learn more by viewing the project report.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).